Cardiovascular Pharmacology

Cardiovascular Pharmacology deals with the study of the effect of drugs upon the heart or the circulatory system. Cardiovascular diseases are a leading cause of hospitalizations and death in the whole world. Developing new therapeutic agents for cardiovascular diseases has always been the priority for the pharmaceutical industry because of the huge potential market for these drugs. Cardiovascular Pharmacology and Therapeutics will focus primarily on drugs used in the treatment of cardiovascular disease, both current drug classes and those in development. It mainly contributes to the safety profile of potential new drugs and provides pharmacological data that can be used for optimization of further compounds and the ultimate selection of compounds suitable for clinical development.

    Related Conference of Cardiovascular Pharmacology

    May 30-31, 2024

    6th Euro Cardiology Congress

    Vienna, Austria
    May 30-31, 2024

    39th World Congress on Heart Diseases

    Vienna, Austria
    June 20-21, 2024

    5th European Summit on Cardiology Research

    Dublin, Ireland
    July 16-17, 2024

    13th World Heart Congress

    Paris, France
    August 01-02, 2024

    38th World Congress on Heart Diseases

    Montreal, Canada
    September 16-17, 2024

    3rd Global Summit on Cardiology and Cardiac Surgery

    Paris, France
    October 24-25, 2024

    11th International Conference on Interventional Cardiology

    Zurich, Switzerland
    October 30-31, 2024

    7th Global Cardiovascular Research and Clinical Cardiology

    Vancouver, Canada

    Cardiovascular Pharmacology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in